Skip to main content
We use cookies to improve our service and to tailor our content and advertising to you.
More info
You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our
cookies policy
.
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Special Edition
Archive
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Special Edition
Archive
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 12, Issue 8
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
Email Alert
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
Statistics from Altmetric.com
Online download statistics by month:
Online download statistics by month: August 2019 to December 2019
Abstract
Full
Pdf
Aug 2019
695
24
17
Sep 2019
1116
32
27
Oct 2019
401
5
3
Nov 2019
140
6
2
Dec 2019
45
2
1
Total
2397
69
50
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF